Gad A Marshall1, Maria Dekhtyar2, Jonathan M Bruno2, Kamal Jethwani3, Rebecca E Amariglio1, Keith A Johnson4, Reisa A Sperling1, Dorene M Rentz1. 1. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA ; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA ; Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA ; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 2. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA ; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. 3. Connected Health Innovation, Partners HealthCare, Harvard Medical School, Boston, MA 02114. 4. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA ; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA ; Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA ; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Abstract
BACKGROUND: Impairment in activities of daily living is a major burden for Alzheimer's disease dementia patients and caregivers. Multiple subjective scales and a few performance-based instruments have been validated and proven to be reliable in measuring instrumental activities of daily living in Alzheimer's disease dementia but less so in amnestic mild cognitive impairment and preclinical Alzheimer's disease. OBJECTIVE: To validate the Harvard Automated Phone Task, a new performance-based activities of daily living test for early Alzheimer's disease, which assesses high level tasks that challenge seniors in daily life. DESIGN: In a cross-sectional study, the Harvard Automated Phone Task was associated with demographics and cognitive measures through univariate and multivariate analyses; ability to discriminate across diagnostic groups was assessed; test-retest reliability with the same and alternate versions was assessed in a subset of participants; and the relationship with regional cortical thickness was assessed in a subset of participants. SETTING: Academic clinical research center. PARTICIPANTS: One hundred and eighty two participants were recruited from the community (127 clinically normal elderly and 45 young normal participants) and memory disorders clinics at Brigham and Women's Hospital and Massachusetts General Hospital (10 participants with mild cognitive impairment). MEASUREMENTS: As part of the Harvard Automated Phone Task, participants navigated an interactive voice response system to refill a prescription (APT-Script), select a new primary care physician (APT-PCP), and make a bank account transfer and payment (APT-Bank). The 3 tasks were scored based on time, errors, and repetitions from which composite z-scores were derived, as well as a separate report of correct completion of the task. RESULTS: We found that the Harvard Automated Phone Task discriminated well between diagnostic groups (APT-Script: p=0.002; APT-PCP: p<0.001; APT-Bank: p=0.02), had an incremental level of difficulty, and had excellent test-retest reliability (Cronbach's α values of 0.81 to 0.87). Within the clinically normal elderly, there were significant associations in multivariate models between performance on the Harvard Automated Phone Task and executive function (APT-PCP: p<0.001), processing speed (APT-Script: p=0.005), and regional cortical atrophy (APT-PCP: p=0.001; no significant association with APT-Script) independent of hearing acuity, motor speed, age, race, education, and premorbid intelligence. CONCLUSIONS: Our initial experience with the Harvard Automated Phone Task, which consists of ecologically valid, easily-administered measures of daily activities, suggests that these tasks could be useful for screening and tracking the earliest functional alterations in preclinical and early prodromal AD.
BACKGROUND: Impairment in activities of daily living is a major burden for Alzheimer's disease dementiapatients and caregivers. Multiple subjective scales and a few performance-based instruments have been validated and proven to be reliable in measuring instrumental activities of daily living in Alzheimer's disease dementia but less so in amnestic mild cognitive impairment and preclinical Alzheimer's disease. OBJECTIVE: To validate the Harvard Automated Phone Task, a new performance-based activities of daily living test for early Alzheimer's disease, which assesses high level tasks that challenge seniors in daily life. DESIGN: In a cross-sectional study, the Harvard Automated Phone Task was associated with demographics and cognitive measures through univariate and multivariate analyses; ability to discriminate across diagnostic groups was assessed; test-retest reliability with the same and alternate versions was assessed in a subset of participants; and the relationship with regional cortical thickness was assessed in a subset of participants. SETTING: Academic clinical research center. PARTICIPANTS: One hundred and eighty two participants were recruited from the community (127 clinically normal elderly and 45 young normal participants) and memory disorders clinics at Brigham and Women's Hospital and Massachusetts General Hospital (10 participants with mild cognitive impairment). MEASUREMENTS: As part of the Harvard Automated Phone Task, participants navigated an interactive voice response system to refill a prescription (APT-Script), select a new primary care physician (APT-PCP), and make a bank account transfer and payment (APT-Bank). The 3 tasks were scored based on time, errors, and repetitions from which composite z-scores were derived, as well as a separate report of correct completion of the task. RESULTS: We found that the Harvard Automated Phone Task discriminated well between diagnostic groups (APT-Script: p=0.002; APT-PCP: p<0.001; APT-Bank: p=0.02), had an incremental level of difficulty, and had excellent test-retest reliability (Cronbach's α values of 0.81 to 0.87). Within the clinically normal elderly, there were significant associations in multivariate models between performance on the Harvard Automated Phone Task and executive function (APT-PCP: p<0.001), processing speed (APT-Script: p=0.005), and regional cortical atrophy (APT-PCP: p=0.001; no significant association with APT-Script) independent of hearing acuity, motor speed, age, race, education, and premorbid intelligence. CONCLUSIONS: Our initial experience with the Harvard Automated Phone Task, which consists of ecologically valid, easily-administered measures of daily activities, suggests that these tasks could be useful for screening and tracking the earliest functional alterations in preclinical and early prodromal AD.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: Donald R Royall; Edward C Lauterbach; Daniel Kaufer; Paul Malloy; Kerry L Coburn; Kevin J Black Journal: J Neuropsychiatry Clin Neurosci Date: 2007 Impact factor: 2.198
Authors: Susan M Landau; Danielle Harvey; Cindee M Madison; Robert A Koeppe; Eric M Reiman; Norman L Foster; Michael W Weiner; William J Jagust Journal: Neurobiol Aging Date: 2009-08-05 Impact factor: 4.673
Authors: C R McDonald; L K McEvoy; L Gharapetian; C Fennema-Notestine; D J Hagler; D Holland; A Koyama; J B Brewer; A M Dale Journal: Neurology Date: 2009-08-11 Impact factor: 9.910
Authors: K L Triebel; R Martin; H R Griffith; J Marceaux; O C Okonkwo; L Harrell; D Clark; J Brockington; A Bartolucci; Daniel C Marson Journal: Neurology Date: 2009-09-22 Impact factor: 9.910
Authors: P Aisen; J Touchon; R Amariglio; S Andrieu; R Bateman; J Breitner; M Donohue; B Dunn; R Doody; N Fox; S Gauthier; M Grundman; S Hendrix; C Ho; M Isaac; R Raman; P Rosenberg; R Schindler; L Schneider; R Sperling; P Tariot; K Welsh-Bohmer; M Weiner; B Vellas Journal: J Prev Alzheimers Dis Date: 2017
Authors: Gad A Marshall; Sarah L Aghjayan; Maria Dekhtyar; Joseph J Locascio; Kamal Jethwani; Rebecca E Amariglio; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: J Prev Alzheimers Dis Date: 2017
Authors: Lee Ashendorf; Michael L Alosco; Hanaan Bing-Canar; Kimberly R Chapman; Brett Martin; Christine E Chaisson; Diane Dixon; Eric G Steinberg; Yorghos Tripodis; Neil W Kowall; Robert A Stern Journal: Arch Clin Neuropsychol Date: 2018-08-01 Impact factor: 2.813
Authors: Sandra Weintraub; Maria C Carrillo; Sarah Tomaszewski Farias; Terry E Goldberg; James A Hendrix; Judith Jaeger; David S Knopman; Jessica B Langbaum; Denise C Park; Michael T Ropacki; Sietske A M Sikkes; Kathleen A Welsh-Bohmer; Lisa J Bain; Robert Brashear; Kumar Budur; Ana Graf; Ferenc Martenyi; Marta Segardahl Storck; Christopher Randolph Journal: Alzheimers Dement (N Y) Date: 2018-02-13
Authors: Gad A Marshall; Sarah L Aghjayan; Maria Dekhtyar; Joseph J Locascio; Kamal Jethwani; Rebecca E Amariglio; Sara J Czaja; David A Loewenstein; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Alzheimers Res Ther Date: 2019-01-10 Impact factor: 6.982
Authors: Gad A Marshall; Sietske A M Sikkes; Rebecca E Amariglio; Jennifer R Gatchel; Dorene M Rentz; Keith A Johnson; Oliver Langford; Chung-Kai Sun; Michael C Donohue; Rema Raman; Paul S Aisen; Reisa A Sperling; Douglas R Galasko Journal: Alzheimers Dement (Amst) Date: 2020-10-30
Authors: Mark A Dubbelman; Roos J Jutten; Sarah E Tomaszewski Farias; Rebecca E Amariglio; Rachel F Buckley; Pieter Jelle Visser; Dorene M Rentz; Keith A Johnson; Michael J Properzi; Aaron Schultz; Nancy Donovan; Jennifer R Gatchell; Charlotte E Teunissen; Bart N M Van Berckel; Wiesje M Van der Flier; Reisa A Sperling; Kathryn V Papp; Philip Scheltens; Gad A Marshall; Sietske A M Sikkes Journal: Alzheimers Res Ther Date: 2020-10-29 Impact factor: 6.982